No, This is what I posted:
"This is why, as soon as I get more cash, that I am going to buy as much as I can at this absolutely rediculous price. I think we can thank those investors who only look at the technicals of a stock and not the quality of a company - these guys are controlling the price. I still give the odds that IDMI will be successful at >> 90% and apparently the PAJO ALTO INVESTORS believe the same."
AS for Junovan, I really have no idea how that will go with the FDA. If it is really true that the rejection was due to a missing document and the consequent failure to review the data associated and the FDA p values turn out to be the same as IDMI, then, I would say it is likely thew FDA will approve Junovan on August 26.